Affiliation:
1. Kitasato Institute for Life Sciences and Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku
2. Pharmaceutical Center, Meiji Seika Kaihsha, Morookacho, Kohoku-ku, Yokohama, Japan
3. Department of Pediatrics, Tokyo National Medical Center, Higashigaoka, Meguro-ku, Tokyo
Abstract
ABSTRACT
The antibiotic susceptibilities, genotypes of penicillin (PEN)-binding protein genes (
pbp
), and serotype distributions of
Streptococcus pneumoniae
isolates from meningitis patients were investigated by a nationwide surveillance group in Japan between 1999 and 2002. We analyzed 146 isolates from children (≤17 years old) and 73 from adults (≥18 years old). Isolates with or without abnormal
pbp1a
,
pbp2x
, or
pbp2b
genes identified by PCR were classified into six genotype patterns and 90% MIC (MIC
90
) values for PEN: (i) strains with three normal genes (17.2% of isolates; MIC
90
, 0.031 μg/ml); (ii) strains with abnormal
pbp2x
(22.1%, 0.063 μg/ml); (iii) strains with abnormal
pbp2b
(1.0%, 0.125 μg/ml); (iv) strains with abnormal
pbp2x
and
pbp2b
(7.4%, 0.25 μg/ml); (v) strains with abnormal
pbp1a
and
pbp2x
(12.7%, 0.25 μg/ml); and (vi) strains with three abnormal PBP genes (39.7%, 4 μg/ml), which are termed genotypic PEN-resistant
S. pneumoniae
(gPRSP). Panipenem, a carbapenem, showed an excellent MIC
90
(0.125 μg/ml) against gPRSP, followed by meropenem and vancomycin (0.5 μg/ml), cefotaxime and ceftriaxone (1 μg/ml), and ampicillin (4 μg/ml). Strains of gPRSP were significantly more prevalent in children (45.2%) than in adults (27.4%). The most frequent serotypes were 6B, 19F, 23F, 6A, and 14 in children and 23F, 22, 3, 10, 6B, and 19F in adults. Serotypes 6B, 6A, 19F, 23F, and 14 predominated among gPRSP. In children, 7- and 11-valent pneumococcal conjugate vaccines would cover 76.2 and 81.3% of isolates, respectively, although coverage would be lower in adults (43.9 and 56.0%, respectively). These findings suggest the need for early introduction of pneumococcal conjugate vaccines and continuous bacteriological surveillance for meningitis.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference47 articles.
1. Advisory Committee on Immunization Practices. 2000. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices. Morb. Mortal. Wkly Rep.49:1-35.
2. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis.15:77-83.
3. Appelbaum, P. C., A. Bhamjee, J. N. Scragg, A. F. Hallett, A. J. Bowen, and R. C. Cooper. 1977. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet2:995-997.
4. Arimasu, O., H. Meguro, H. Shiraishi, K. Sugamata, and F. Hiruma. 1988. A case of pneumococcal meningitis resistant to beta-lactam antibiotic treatment. Kansenshogaku Zasshi.62:682-683. (In Japanese.)
5. Association of a Thr-371 Substitution in a Conserved Amino Acid Motif of Penicillin-Binding Protein 1A with Penicillin Resistance of
Streptococcus pneumoniae